AAAAAA

   
Results: 1-11 |
Results: 11

Authors: LI J GYORFFY SF LIAW PCY RING DB DOVE JH KWOK CS AUSTIN RC
Citation: J. Li et al., PREPARATION AND CHARACTERIZATION OF A HUMANIZED 520C9 SINGLE-CHAIN FVHUMAN INTERLEUKIN-2 FUSION PROTEIN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 3-3

Authors: CLARK JI ALPAUGH RK VONMEHREN M SCHULTZ J GRALOW JR CHEEVER MA RING DB WEINER LM
Citation: Ji. Clark et al., INDUCTION OF MULTIPLE ANTI-C-ERB-2 SPECIFICITIES ACCOMPANIES A CLASSICAL IDIOTYPIC CASCADE FOLLOWING 2B1 BISPECIFIC MONOCLONAL-ANTIBODY TREATMENT, Cancer immunology and immunotherapy, 44(5), 1997, pp. 265-272

Authors: WEINER LM ALPAUGH RK AMOROSO AR ADAMS GP RING DB BARTH MW
Citation: Lm. Weiner et al., HUMAN NEUTROPHIL INTERACTIONS OF A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING TUMOR AND HUMAN FC-GAMMA-RIII, Cancer immunology and immunotherapy, 42(3), 1996, pp. 141-150

Authors: HSIEHMA ST SHI T REEDER J RING DB
Citation: St. Hsiehma et al., IN-VITRO TUMOR-GROWTH INHIBITION BY BISPECIFIC ANTIBODIES TO HUMAN TRANSFERRIN RECEPTOR AND TUMOR-ASSOCIATED ANTIGENS IS AUGMENTED BY THE IRON CHELATOR DEFEROXAMINE, Clinical immunology and immunopathology, 80(2), 1996, pp. 185-193

Authors: SHI T HSIEHMA ST REEDER J RING DB
Citation: T. Shi et al., MURINE BISPECIFIC ANTIBODY 1A10 DIRECTED TO HUMAN TRANSFERRIN RECEPTOR AND A 42-KDA TUMOR-ASSOCIATED GLYCOPROTEIN, Clinical immunology and immunopathology, 78(2), 1996, pp. 188-195

Authors: AMOROSO AR CLARK JI LITWIN S HSIEHMA S SHI T ALPAUGH RK ADAMS GP WOLF EJ RING DB WEINER LM
Citation: Ar. Amoroso et al., BINDING CHARACTERISTICS AND ANTITUMOR PROPERTIES OF 1A10 BISPECIFIC ANTIBODY RECOGNIZING GP40 AND HUMAN TRANSFERRIN RECEPTOR, Cancer research, 56(1), 1996, pp. 113-120

Authors: SHI T WRIN J REEDER J LIU D RING DB
Citation: T. Shi et al., HIGH-AFFINITY MONOCLONAL-ANTIBODIES AGAINST P-GLYCOPROTEIN, Clinical immunology and immunopathology, 76(1), 1995, pp. 44-51

Authors: WEINER LM CLARK JI DAVEY M LI WS DEPALAZZO IG RING DB ALPAUGH RK
Citation: Lm. Weiner et al., PHASE-I TRIAL OF 2B1, A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING C-ERBB-2 AND FC-GAMMA-RIII, Cancer research, 55(20), 1995, pp. 4586-4593

Authors: INLOW D LOWE D HOWARTH B MACDONALD H HARANO D DAVIS J MAIORELLA B BRANNON M FORDHAM D LIN L REEDER J RING DB
Citation: D. Inlow et al., IMPROVEMENTS IN HYBRIDOMA CULTURE AND BISPECIFIC ANTIBODY-PRODUCTION, Journal of cellular biochemistry, 1994, pp. 188-188

Authors: RING DB HSIEHMA ST SHI T REEDER J
Citation: Db. Ring et al., ANTIGEN FORKS - BISPECIFIC REAGENTS THAT INHIBIT CELL-GROWTH BY BINDING SELECTED PAIRS OF TUMOR-ANTIGENS, Cancer immunology and immunotherapy, 39(1), 1994, pp. 41-48

Authors: WEINER LM HOLMES M RICHESON A GODWIN A ADAMS GP HSIEHMA ST RING DB ALPAUGH RK
Citation: Lm. Weiner et al., BINDING AND CYTOTOXICITY CHARACTERISTICS OF THE BISPECIFIC MURINE MONOCLONAL ANTIBODY-2B1, The Journal of immunology, 151(5), 1993, pp. 2877-2886
Risultati: 1-11 |